- NSE
- SHALBY
- BSE
- 540797
- ISIN
- INE597J01018
SHALBY
Healthcare· Healthcare Services· Hospital
₹127.36
+₹1.84 (+1.47%)
NSE close ·
SHALBY closed at ₹127.36 on 12 Nov 2026, up 1.47% on the day, and is down 44.33% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹113.39 to ₹230.31.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,376 Cr
- Industry P/E
- 56.4
- Dividend yield
- 0.00%
Market cap and yield at the 12 Nov 2026 close. Industry P/E is the median of 6 Healthcare Services stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹339 Cr | ₹10.50 Cr | — | ₹0.98 |
Armor risk check
SHALBY moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is SHALBY's share price today?
SHALBY (NSE: SHALBY) closed at ₹127.36 on 12 Nov 2026, up 1.47% from the previous close of ₹125.52. It traded between ₹124.00 and ₹128.99 that day.
What are SHALBY's 52-week high and low?
Over the last 52 weeks SHALBY traded between ₹110.61 and ₹237.40, adjusted for splits and bonuses.
What are SHALBY's NSE symbol, BSE code and ISIN?
SHALBY has NSE symbol SHALBY, BSE code 540797, ISIN INE597J01018.
How has SHALBY performed over 1, 3 and 5 years?
SHALBY's share price return: 1Y −44.33%, 3Y −23.87% a year, 5Y −2.91% a year. Dividends are not included.
Does SHALBY pay a dividend?
Yes. SHALBY's latest dividend went ex on 19 Sep 2024: Final · ₹1.20 per share.
What is SHALBY's market cap?
SHALBY's market cap is ₹1,376 Cr at the close on 12 Nov 2026.
Which sector is SHALBY in?
SHALBY is in NSE's Healthcare sector, in the Healthcare Services industry (Hospital).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how SHALBY fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app